Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases |
|---|---|
| Disease/Condition | Blood Disorders and Diseases,Hematologic Diseases,Sickle Cell,Anemia |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Caterina Minniti, MD |
| Contact Name | Shuo You |
| Contact Email | shuo.you@einstein.yu.edu |
| IRB/Protocol Number | 2016-7119 |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Hematology - Sickle Cell Disease |
